ECTRIMS 2021

Changes in GABA-receptor binding among cognitively impaired MS patients

Presented By

Prof. Hanneke Hulst, Leiden University, Netherlands

Conference

ECTRIMS 2021

18 October, 2021 10:46

MS patients at risk of hampered immune response after SARS-CoV-2 mRNA vaccination

Presented By

Dr Maria Pia Sormani , University of Genoa, Italy

Conference

ECTRIMS 2021

18 October, 2021 10:44

Ublituximab meets primary endpoint for relapsing MS

Presented By

Prof. Lawrence Steinman, Stanford University, CA, USA

Trial

Phase 3, ULTIMATE I; ULTIMATE II

Conference

ECTRIMS 2021

18 October, 2021 10:42

Ibudilast reduced retinal atrophy in primary progressive MS

Presented By

Dr Henrik Ehrhardt, John Hopkins University, MD, USA

Trial

Phase 2, SPRINT-MS

Conference

ECTRIMS 2021

18 October, 2021 10:40

Ocrelizumab shows long-term benefits in primary progressive MS

Presented By

Dr Jerry Wolinsky, University of Texas Health Science Center at Houston, TX, USA

Trial

Phase 3, ORATORIO

Conference

ECTRIMS 2021

18 October, 2021 10:37

Early predictors of disability progression in paediatric-onset MS

Presented By

Dr Sifat Sharmin, University of Melbourne, Australia

Conference

ECTRIMS 2021

18 October, 2021 10:32

Is there a multiple sclerosis personality?

Presented By

Laura Chu, Western University, Canada

Conference

ECTRIMS 2021

15 October, 2021 11:50

MRI more sensitive for disease activity than relapses in SPMS

Presented By

Prof. Gavin Giovannoni, Queen Mary University of London, UK

Trial

Phase 3, EXPAND

Conference

ECTRIMS 2021

15 October, 2021 11:47

Immunotherapy in MS does not influence COVID-19 severity and mortality

Presented By

Dr Gabriel Bsthe, medical university of Vienna, Austria

Conference

ECTRIMS 2021

15 October, 2021 11:44

Cortical lesions at diagnosis predict cognitive impairment 20 years later

Presented By

Stefano Ziccardi, University of Verona, Italy

Conference

ECTRIMS 2021

15 October, 2021 11:41

Dynamic scoring system aids decision to switch MS-therapies early

Presented By

Camille Sabathé, French Institute of Health and Medical Research, France

Conference

ECTRIMS 2021

15 October, 2021 11:37

Evobrutinib reduces relapse and MRI lesion activity

Presented By

Jens Kuhle, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel, Switzerland

Conference

ECTRIMS 2021

15 October, 2021 11:27

Melatonin associated with improved sleep quality in MS patients

Presented By

Mr. Wan-Yu Hsu, University of California, CA, USA

Conference

ECTRIMS 2021

14 October, 2021 11:28

Preliminary data shows positive results of ATA188 for progressive MS

Presented By

Dr Douglas Arnold, McGill University, Canada

Trial

Phase 1

Conference

ECTRIMS 2021

14 October, 2021 11:25

Cortical lesions at diagnosis predict disease progression and disability accumulation in MS

Presented By

Dr Gian Marco Schiavi, University of Verona, Italy

Conference

ECTRIMS 2021

14 October, 2021 11:22

Satralizumab demonstrates long-term efficacy in patients with neuromyelitis optica spectrum disorder

Presented By

Dr Ingo Kleiter, Ruhr-Universität Bochum, Germany

Trial

SAkuraSky; SAkuraStar

14 October, 2021 11:20

High-sensitive biomarker detection in MS via novel ELISA assay

Presented By

Prof. Maria Cruz Sádaba, Private University San Pablo CEU, Spain

Conference

ECTRIMS 2021

14 October, 2021 11:17

Rituximab most effective initial MS therapy in Swedish real-world study

Presented By

Dr. Peter Alping, Karolinska Institute, Sweden

Conference

ECTRIMS 2021

14 October, 2021 11:12